Loading…
99,167 grants found
Showing 3,261 – 3,280 of 99,167 grants
ABSTRACT: This U01 application aims to (1) develop a robust protoacoustic dosimeter for 3D in vivo dosimetry in proton FLASH therapy, which is essential for its clinical applicatio...
Project Summary/Abstract The long-term goal of our research program is to assess the natural disease state of age-related changes in the vestibular system and improve clinical diag...
B lymphocytes are critical players in the development of protective immunity, as well as in pathological states such as autoimmunity. Careful regulation of the strength and quality...
PROJECT SUMMARY – OVERALL: MACHINE LEARNING-ENABLED DESIGN OF PROTOTYPE PATHOGEN VACCINES AND ANTIBODIES We propose a highly synergistic Center focused on developing end-to-end str...
PROJECT SUMMARY – CORE A: ADMINISTRATIVE The Administrative Core will coordinate the scientific, administrative, and financial functions of our multi-project, multi-institution Cen...
PROJECT SUMMARY – CORE B: DATA MANAGEMENT The Data Management Core will create, operate, and maintain state-of-the-art computer systems to store and safeguard the diverse types of...
PROJECT SUMMARY – CORE C: VACCINE PRODUCTION AND PROCESS DEVELOPMENT The Vaccine Production and Process Development Core will provide both high-throughput and scalable biologics pr...
PROJECT SUMMARY – CORE D: ANIMAL MODELS AND VACCINE EVALUATION Among viruses that cause disease in humans viral zoonoses within the family Paramyxoviridae and order Bunyavirales co...
PROJECT SUMMARY – CORE E: PHYLOGENETIC AND MUTATIONAL SCANNING This Core will use cutting-edge experimental and computational techniques to ensure that the vaccines target the full...
PROJECT SUMMARY – PROJECT 1: COMPUTATIONAL METHODS Project 1 will develop the general computational methods that underpin our Center’s approaches to vaccine and antibody design. In...
PROJECT SUMMARY – PROJECT 2: VIRAL ENTRY, ANTIBODIES, AND STRUCTURAL BIOLOGY Studies of viral glycoproteins and their interactions with receptors and antibodies are paramount to va...
PROJECT SUMMARY – PROJECT 3: ANTIGEN DESIGN Project 3 focuses on developing generalizable approaches to the modeling, design, and evaluation of native-like antigens for arenaviruse...
PROJECT SUMMARY – PROJECT 4: PROTEIN NANOPARTICLE VACCINES Project 4 focuses on developing generalizable approaches to the design, production, and evaluation of two-component prote...
PROJECT SUMMARY – PROJECT 5: mRNA AND mRNA-LAUNCHED NANOPARTICLE VACCINES The goal of Project 5 is to develop generalizable approaches and platforms to design, make, and evaluate m...
SUMMARY. The Flavivirus and Alphavirus ReVAMPP (FLARE) Center will develop and optimize protein nanoparticle, virion-based, and mRNA vaccine platforms, and monoclonal antibody (mAb...
Core A (Administrative Core) Summary The Administrative Core A (hereafter, Core A) will serve as the central entity to direct, oversee, and ensure the mission of the Flavivirus and...
Summary, Data Mangement Core B The Data Management Core B (hereafter, Core B) will be the nexus for all data management, analysis, and harmonization activities in the Flavivirus an...
SUMMARY Flaviviruses and alphaviruses are enveloped, single-stranded RNA viruses that cause epidemics of human disease on a global scale, with new virus members regularly emerging...
SUMMARY Flaviviruses and alphaviruses are emerging arthropod-borne viruses that cause severe and often life-threatening disease in humans, and ongoing and recent epidemics have inf...
Flaviviruses and alphaviruses are enveloped, single-stranded RNA viruses that cause epidemics of human disease on a global scale, with new family members regularly emerging and cau...